Cleared Traditional

K051966 - FIRST CHECK MULTI DRUG CUP 7 FOR MARIJUANA (THC), COCAINE (COC), AMPHETAMINE (AMP), METHAMPHETAMINE (MET), ECSTASY

K051966 is an FDA 510(k) clearance for FIRST CHECK MULTI DRUG CUP 7 FOR MARIJU..., manufactured by Worldwide Medical, LLC. The device is a Class 2 Toxicology device with product code DKZ cleared through the Traditional 510(k) pathway after a 49-day FDA review.

K051966 · Worldwide Medical, LLC · Toxicology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2005
Decision
49d
Days
Class 2
Risk

K051966 is an FDA 510(k) clearance for the FIRST CHECK MULTI DRUG CUP 7 FOR MARIJUANA (THC), COCAINE (COC), AMPHETAMINE .... Classified as Enzyme Immunoassay, Amphetamine (product code DKZ), Class II - Special Controls.

Submitted by Worldwide Medical, LLC (Lake Forest, US). The FDA issued a Cleared decision on September 7, 2005 after a review of 49 days - a notably fast clearance cycle.

This device falls under the Toxicology FDA review panel, regulated under 21 CFR 862.3100 - the FDA toxicology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Worldwide Medical, LLC devices

FDA 510(k) Submission Details - K051966

510(k) Number K051966 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 20, 2005
Decision Date September 07, 2005
Days to Decision 49 days
Submission Type Traditional
Review Panel Toxicology (TX)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
38d faster than avg
Panel avg: 87d · This submission: 49d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DKZ Device Classification - Class 2, Special Controls

Product Code DKZ Enzyme Immunoassay, Amphetamine
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.3100
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Toxicology devices follow this clearance model.

Regulatory Peers - DKZ Enzyme Immunoassay, Amphetamine

All 195
Devices cleared under the same product code (DKZ) and FDA review panel - the closest regulatory comparables to K051966.
QUEST DIAGNOSTICS HAIRCHECK-DT (AMPHETAMINES)
K051161 · Quest Diagnostics, Inc. · Nov 2005
SURE-SCREEN AMPHETAMINE, BENZODIAZEPINE, COCAINE, METHAMPHETAMINE/MDMA, METHADONE, OPIATES, PHENCYCLIDINE & CANNABINOIDS
K050394 · Medtox Diagnostics, Inc. · Oct 2005
IMMUNALYSIS AMPHETAMINE ELISA FOR ORAL FLUIDS
K051579 · Immunalysis Corporation · Oct 2005
RAPID READER
K041696 · American Bio Medica Corp. · Jul 2005
ON TRAK TESTCARD
K051235 · Varian, Inc. · Jun 2005
UCP RAPID DRUG SCREENING TESTS
K050540 · Ucp Biosciences, Inc. · Apr 2005